Figure S4 from PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma

<p>Melanoma-specific survival Validation Set. PD-L1 negative/CD8A low was associated with worse survival versus PD-L1 positive/CD8A low or PD-L1 positive/CD8A high (p = 0.014; log rank). An outlier case of PD-L1 negative/CD8A high was also observed in the validation set.</p>